SpringWorks Therapeutics springs higher as Merck KGaA takeover said close

April 25, 2025 06:15 AM AEST | By Investing

Google News:

SpringWorks Therapeutics springs higher as Merck KGaA takeover said close

Recent News

"Aptos EXPO Memorial Stamp Rally" Goes Live in Celebration of Expo 202...

MEXC Unveils New Launchpad Featuring BTC to Kick Off BTC Trading Month

PolicyStreet Launches Flash Sale to Help Malaysians Manage Car Costs A...

Chula-Harvard Collaboration Marks a Milestone in Globalizing Thai Inte...

Investing.com -- Shares of SpringWorks Therapeutics Inc (NASDAQ:SWTX) surged higher Thursday afternoon on reports that a potential takeover of the company by Germany’s Merck KGaA (ETR:MRCG) is getting close.

This afternoon, The Wall Street Journal reported that the two companies are near a $47 per share takeover deal and a definitive agreement could be announced as soon as Monday, citing people familiar with the matter.

Shares of SpringWorks last traded up 8% to $44.50.

The potential deal has been in the works since at least February, when Merck KGaA confirmed it was in advanced talks to acquire the cancer and rare diseases drugmaker.

Earlier in the week, an analyst at Barclays (LON:BARC) highlighted that a just-concluded CHMP meeting on SpringWorks' Ogsiveo could help de-risk the potential deal. EU approval of Ogsiveo is seen as a key catalyst for a takeover.

Ogsiveo is the first FDA-approved therapy for patients with desmoid tumors who require systemic treatment. The drug was approved by the FDA in November 2023.

This article first appeared in Investing.com

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.